同花顺财经

摩根士丹利:给予同仁堂国药(03613.HK)“增持”评级 目标价17.80港元

2018-12-07 18:01:11      同花顺财经      

  摩根士丹利12月6日发布公告。From 2016-2018, the caps were HK$17.4mn, HK$23.2mn, and HK$26.5mn. The renewed contract specifies caps of HK$31.0mn, HK$42.0mn, and HK$55.0mn for 2019-2021, representing annual increases of 17%, 35%, and 31%. While these amounts have factored in management"s expectations for higher raw material costs, appreciation of Rmb against HK$, and a certain buffer for supply, we believe they also speak to robust demand expected in the next three years in HK and Macau.

以上资讯由同花顺AI写手完成,写作系统尚处于测试阶段,内容仅供参考。

21